
Nick Goeden
Co-Founder and Chief Technology Officer
Nick Goeden, Ph.D., is the co-founder and CTO at Capsida Biotherapeutics. Nick is focused on developing safer and more effective next-generation gene therapies that will provide disease-modifying therapies for severe CNS and ophthalmology disorders not possible with early generation approaches. His innovation in adeno-associated virus engineering while a postdoctoral fellow at Caltech led him to co-found Capsida Biotherapeutics to improve upon the limitations of wildtype serotypes. Nick holds a B.S. in biology from Caltech and a Ph.D. in neuroscience from the University of Southern California and is the co-inventor on over 50 patent applications.